Publications by authors named "Ashish P Anovadiya"
Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection.
J Infect Dis
January 2020
Article Synopsis
- - A study examined how neuraminidase inhibitors (NAIs) affect the length of hospital stays for patients with influenza A(H1N1)pdm09 by analyzing data from over 18,000 individuals from 70 clinical centers.
- - Results indicated that starting NAI treatment upon hospitalization leads to a 19% decrease in length of stay compared to starting later or not at all, with consistent findings across different patient groups.
- - The study concluded that immediate NAI treatment for hospitalized influenza patients correlates with shorter hospital stays compared to delayed treatment or no treatment, regardless of when symptoms began.
Evaluation of wound healing activity of cow urine ark in diabetic Wistar albino rats.
J Intercult Ethnopharmacol
September 2016
Aim: To evaluate wound healing activity of cow urine ark in diabetic rats.
Materials And Methods: Streptozotocin-induced diabetic Wistar albino rats were randomly divided into six groups ( = 6). Three groups - diabetic control, active control (glibenclamide), and treatment (cow urine ark) were operated for excision wounds (EWs).
Background: The impact of neuraminidase inhibitors (NAIs) on influenza-related pneumonia (IRP) is not established. Our objective was to investigate the association between NAI treatment and IRP incidence and outcomes in patients hospitalised with A(H1N1)pdm09 virus infection.
Methods: A worldwide meta-analysis of individual participant data from 20 634 hospitalised patients with laboratory-confirmed A(H1N1)pdm09 (n = 20 021) or clinically diagnosed (n = 613) 'pandemic influenza'.
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Lancet Respir Med
May 2014
Article Synopsis
- The study analyzed the effectiveness of neuraminidase inhibitors in reducing mortality among hospitalized patients with the H1N1 virus during the pandemic.
- Data from 29,234 patients across 78 studies was examined to assess the impact of these antiviral treatments.
- Results showed that neuraminidase inhibitors reduced mortality risk, particularly when administered early (within two days of symptom onset), highlighting the importance of prompt treatment.
Purpose: To evaluate effect of ethanolic extract of Pedalium murex Linn. fruits on experimental model of calcium oxalate nephrolithiasis.
Materials And Methods: Thirty-six male Wistar albino rats were randomly divided in 6 groups.
A 55 years old male patient, who is planned for bronchoscopy developed central anti-cholinergic syndrome due to therapeutic dose of atropine. Withdrawal of atropine has improved the symptoms. Thereafter, instillation of atropine as eye drops leads to reappearance of symptoms.
View Article and Find Full Text PDFDespite of established and effective therapy for epilepsy, 20-25% patients develop therapeutic failure; this encourages finding newer drugs. Novel approaches target receptors which remain unaffected by conventional therapy or inhibit epileptogenesis. AMPA receptor antagonists have shown faster and complete protection compared to diazepam.
View Article and Find Full Text PDFSeven years old male child (24 kg weight) diagnosed as a case of sub acute appendicitis treated with ciprofloxacin, immediately developed multiple erythmatous papules. Reaction subsided after withholding ciprofloxacin and treatment with dexamethasone and chlorpheneramine maleate. It was developed again when treated with levofloxacin and subsided after withdrawal.
View Article and Find Full Text PDFObjectives: To analyze the pattern of adverse drug reactions (ADRs) of oseltamivir and its comparison with available data.
Materials And Methods: Suspected or confirmed cases of H1N1 influenza A on therapeutic regimen and close contacts of cases H1N1 influenza A on prophylactic regimen of oseltamivir were included. Data were collected by personal interview after obtaining written informed consent.